152 related articles for article (PubMed ID: 32748295)
21. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens.
Kimura K; Tsuzuki T; Kato M; Saito AM; Sassa N; Ishida R; Hirabayashi H; Yoshino Y; Hattori R; Gotoh M
Prostate; 2014 May; 74(6):680-7. PubMed ID: 24481730
[TBL] [Abstract][Full Text] [Related]
23. Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens.
Rijstenberg LL; Hansum T; Hollemans E; Kweldam CF; Kümmerlin IP; Bangma CH; van der Kwast TH; Roobol MJ; van Leenders GJLH
Histopathology; 2020 Nov; 77(5):742-748. PubMed ID: 32542746
[TBL] [Abstract][Full Text] [Related]
24. Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
van Leenders GJLH; Kweldam CF; Hollemans E; Kümmerlin IP; Nieboer D; Verhoef EI; Remmers S; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ
Eur Urol; 2020 Feb; 77(2):191-198. PubMed ID: 31439369
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort.
Trudel D; Downes MR; Sykes J; Kron KJ; Trachtenberg J; van der Kwast TH
Eur J Cancer; 2014 Jun; 50(9):1610-6. PubMed ID: 24703897
[TBL] [Abstract][Full Text] [Related]
27. Features and Prognostic Significance of Intraductal Carcinoma of the Prostate.
Montironi R; Zhou M; Magi-Galluzzi C; Epstein JI
Eur Urol Oncol; 2018 May; 1(1):21-28. PubMed ID: 31100224
[TBL] [Abstract][Full Text] [Related]
28. Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
Wu T; Zhao J; Liu Z; Shen P; Zhang M; Sun G; Liu J; Liao B; Chen J; Zhu S; Dai J; Wang Z; Zhang H; Zhao P; Zhang X; Zhu X; Ni Y; Chen N; Zeng H
Prostate; 2019 Oct; 79(14):1673-1682. PubMed ID: 31433509
[TBL] [Abstract][Full Text] [Related]
29. Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Egevad L; Judge M; Delahunt B; Humphrey PA; Kristiansen G; Oxley J; Rasiah K; Takahashi H; Trpkov K; Varma M; Wheeler TM; Zhou M; Srigley JR; Kench JG
Pathology; 2019 Jan; 51(1):11-20. PubMed ID: 30477882
[TBL] [Abstract][Full Text] [Related]
30. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center.
Nie L; Pan X; Zhang M; Yin X; Gong J; Chen X; Xu M; Zhou Q; Chen N
Prostate; 2019 Jun; 79(8):819-825. PubMed ID: 30900303
[TBL] [Abstract][Full Text] [Related]
31. Histopathological features of intra-ductal carcinoma of prostatic and high grade prostatic intraepithelialneoplasia and correlation with PTEN and P63.
Torabi-Nezhad S; Malekmakan L; Mashayekhi M; Daneshian A
Prostate; 2016 Mar; 76(4):394-401. PubMed ID: 26643011
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.
Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
Hum Pathol; 2014 Aug; 45(8):1572-81. PubMed ID: 24842280
[TBL] [Abstract][Full Text] [Related]
33. Population-based study of the incidence and survival for intraductal carcinoma of the prostate.
Dinerman BF; Khani F; Golan R; Bernstein AN; Cosiano MF; Margolis DJ; Hu JC
Urol Oncol; 2017 Dec; 35(12):673.e9-673.e14. PubMed ID: 28919182
[TBL] [Abstract][Full Text] [Related]
34. Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC).
Francini E; Gray KP; Xie W; Shaw GK; Valença L; Bernard B; Albiges L; Harshman LC; Kantoff PW; Taplin ME; Sweeney CJ
Prostate; 2018 Sep; 78(12):889-895. PubMed ID: 29707790
[TBL] [Abstract][Full Text] [Related]
35. How many cores should be taken in a repeat biopsy on patients in whom atypical small acinar proliferation has been identified in an initial transrectal prostate biopsy?
Aglamis E; Kocaarslan R; Yucetas U; Toktas G; Ceylan C; Doluoglu OG; Unluer E
Int Braz J Urol; 2014; 40(5):605-12. PubMed ID: 25498271
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men.
Shoji S; Hiraiwa S; Ogawa T; Kawakami M; Nakano M; Hashida K; Sato Y; Hasebe T; Uchida T; Tajiri T
Int J Urol; 2017 Apr; 24(4):288-294. PubMed ID: 28222486
[TBL] [Abstract][Full Text] [Related]
37. Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells.
Porter LH; Hashimoto K; Lawrence MG; Pezaro C; Clouston D; Wang H; Papargiris M; Thorne H; Li J; ; Ryan A; Norden S; Moon D; Bolton DM; Sengupta S; Frydenberg M; Murphy DG; Risbridger GP; Taylor RA
BJU Int; 2018 Jun; 121(6):971-978. PubMed ID: 28977728
[TBL] [Abstract][Full Text] [Related]
38. Comparison Between a Combined Transrectal and Transperineal Approach and a Transrectal Approach for Prostate Rebiopsy.
Shida Y; Hakariya T; Takehara K; Onita T; Miyata Y; Sakai H
Anticancer Res; 2016 Sep; 36(9):4685-90. PubMed ID: 27630313
[TBL] [Abstract][Full Text] [Related]
39. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
[TBL] [Abstract][Full Text] [Related]
40. The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival.
Trinh VQ; Sirois J; Benzerdjeb N; Mansoori BK; Grosset AA; Albadine R; Latour M; Mes-Masson AM; Hovington H; Bergeron A; Ladouceur M; Fradet Y; Saad F; Trudel D
Prostate; 2018 Jul; 78(10):697-706. PubMed ID: 29603326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]